Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein

Francesco Fornai, Oliver M. Schlüter, Paola Lenzi, Marco Gesi, Riccardo Ruffoli, Michela Ferrucci, Gloria Lazzeri, Carla L. Busceti, Fabrizio Pontarelli, Giuseppe Battaglia, Antonio Pellegrini, Ferdinando Nicoletti, Stefano Ruggieri, Antonio Paparelli, Thomas C. Südhof

Research output: Contribution to journalArticle

Abstract

In animals, sporadic injections of the mitochondrial toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively damage dopaminergic neurons but do not fully reproduce the features of human Parkinson's disease. We have now developed a mouse Parkinson's disease model that is based on continuous MPTP administration with an osmotic minipump and mimics many features of the human disease. Although both sporadic and continuous MPTP administration led to severe striatal dopamine depletion and nigral cell loss, we find that only continuous administration of MPTP produced progressive behavioral changes and triggered formation of nigral inclusions immunoreactive for ubiquitin and α-synuclein. Moreover, only continuous MPTP infusions caused long-lasting activation of glucose uptake and inhibition of the ubiquitin-proteasome system. In mice lacking α-synuclein, continuous MPTP delivery still induced metabolic activation, but induction of behavioral symptoms and neuronal cell death were almost completely alleviated. Furthermore, the inhibition of the ubiquitin-proteasome system and the production of inclusion bodies were reduced. These data suggest that continuous low-level exposure of mice to MPTP causes a Parkinson-like syndrome in an α-synuclein-dependent manner.

Original languageEnglish
Pages (from-to)3413-3418
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number9
DOIs
Publication statusPublished - Mar 1 2005

Fingerprint

Synucleins
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Proteasome Endopeptidase Complex
Ubiquitin
Substantia Nigra
Parkinson Disease
Corpus Striatum
Behavioral Symptoms
Dopaminergic Neurons
Inclusion Bodies
Dopamine
Cell Death
Glucose
Injections

Keywords

  • Lewy bodies
  • Mitochondria
  • Neurodegeneration
  • Neuronal inclusions

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Parkinson-like syndrome induced by continuous MPTP infusion : Convergent roles of the ubiquitin-proteasome system and α-synuclein. / Fornai, Francesco; Schlüter, Oliver M.; Lenzi, Paola; Gesi, Marco; Ruffoli, Riccardo; Ferrucci, Michela; Lazzeri, Gloria; Busceti, Carla L.; Pontarelli, Fabrizio; Battaglia, Giuseppe; Pellegrini, Antonio; Nicoletti, Ferdinando; Ruggieri, Stefano; Paparelli, Antonio; Südhof, Thomas C.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 9, 01.03.2005, p. 3413-3418.

Research output: Contribution to journalArticle

Fornai, Francesco ; Schlüter, Oliver M. ; Lenzi, Paola ; Gesi, Marco ; Ruffoli, Riccardo ; Ferrucci, Michela ; Lazzeri, Gloria ; Busceti, Carla L. ; Pontarelli, Fabrizio ; Battaglia, Giuseppe ; Pellegrini, Antonio ; Nicoletti, Ferdinando ; Ruggieri, Stefano ; Paparelli, Antonio ; Südhof, Thomas C. / Parkinson-like syndrome induced by continuous MPTP infusion : Convergent roles of the ubiquitin-proteasome system and α-synuclein. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 9. pp. 3413-3418.
@article{aced76952a56454cb7aa00996c268868,
title = "Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein",
abstract = "In animals, sporadic injections of the mitochondrial toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively damage dopaminergic neurons but do not fully reproduce the features of human Parkinson's disease. We have now developed a mouse Parkinson's disease model that is based on continuous MPTP administration with an osmotic minipump and mimics many features of the human disease. Although both sporadic and continuous MPTP administration led to severe striatal dopamine depletion and nigral cell loss, we find that only continuous administration of MPTP produced progressive behavioral changes and triggered formation of nigral inclusions immunoreactive for ubiquitin and α-synuclein. Moreover, only continuous MPTP infusions caused long-lasting activation of glucose uptake and inhibition of the ubiquitin-proteasome system. In mice lacking α-synuclein, continuous MPTP delivery still induced metabolic activation, but induction of behavioral symptoms and neuronal cell death were almost completely alleviated. Furthermore, the inhibition of the ubiquitin-proteasome system and the production of inclusion bodies were reduced. These data suggest that continuous low-level exposure of mice to MPTP causes a Parkinson-like syndrome in an α-synuclein-dependent manner.",
keywords = "Lewy bodies, Mitochondria, Neurodegeneration, Neuronal inclusions",
author = "Francesco Fornai and Schl{\"u}ter, {Oliver M.} and Paola Lenzi and Marco Gesi and Riccardo Ruffoli and Michela Ferrucci and Gloria Lazzeri and Busceti, {Carla L.} and Fabrizio Pontarelli and Giuseppe Battaglia and Antonio Pellegrini and Ferdinando Nicoletti and Stefano Ruggieri and Antonio Paparelli and S{\"u}dhof, {Thomas C.}",
year = "2005",
month = "3",
day = "1",
doi = "10.1073/pnas.0409713102",
language = "English",
volume = "102",
pages = "3413--3418",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "9",

}

TY - JOUR

T1 - Parkinson-like syndrome induced by continuous MPTP infusion

T2 - Convergent roles of the ubiquitin-proteasome system and α-synuclein

AU - Fornai, Francesco

AU - Schlüter, Oliver M.

AU - Lenzi, Paola

AU - Gesi, Marco

AU - Ruffoli, Riccardo

AU - Ferrucci, Michela

AU - Lazzeri, Gloria

AU - Busceti, Carla L.

AU - Pontarelli, Fabrizio

AU - Battaglia, Giuseppe

AU - Pellegrini, Antonio

AU - Nicoletti, Ferdinando

AU - Ruggieri, Stefano

AU - Paparelli, Antonio

AU - Südhof, Thomas C.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - In animals, sporadic injections of the mitochondrial toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively damage dopaminergic neurons but do not fully reproduce the features of human Parkinson's disease. We have now developed a mouse Parkinson's disease model that is based on continuous MPTP administration with an osmotic minipump and mimics many features of the human disease. Although both sporadic and continuous MPTP administration led to severe striatal dopamine depletion and nigral cell loss, we find that only continuous administration of MPTP produced progressive behavioral changes and triggered formation of nigral inclusions immunoreactive for ubiquitin and α-synuclein. Moreover, only continuous MPTP infusions caused long-lasting activation of glucose uptake and inhibition of the ubiquitin-proteasome system. In mice lacking α-synuclein, continuous MPTP delivery still induced metabolic activation, but induction of behavioral symptoms and neuronal cell death were almost completely alleviated. Furthermore, the inhibition of the ubiquitin-proteasome system and the production of inclusion bodies were reduced. These data suggest that continuous low-level exposure of mice to MPTP causes a Parkinson-like syndrome in an α-synuclein-dependent manner.

AB - In animals, sporadic injections of the mitochondrial toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively damage dopaminergic neurons but do not fully reproduce the features of human Parkinson's disease. We have now developed a mouse Parkinson's disease model that is based on continuous MPTP administration with an osmotic minipump and mimics many features of the human disease. Although both sporadic and continuous MPTP administration led to severe striatal dopamine depletion and nigral cell loss, we find that only continuous administration of MPTP produced progressive behavioral changes and triggered formation of nigral inclusions immunoreactive for ubiquitin and α-synuclein. Moreover, only continuous MPTP infusions caused long-lasting activation of glucose uptake and inhibition of the ubiquitin-proteasome system. In mice lacking α-synuclein, continuous MPTP delivery still induced metabolic activation, but induction of behavioral symptoms and neuronal cell death were almost completely alleviated. Furthermore, the inhibition of the ubiquitin-proteasome system and the production of inclusion bodies were reduced. These data suggest that continuous low-level exposure of mice to MPTP causes a Parkinson-like syndrome in an α-synuclein-dependent manner.

KW - Lewy bodies

KW - Mitochondria

KW - Neurodegeneration

KW - Neuronal inclusions

UR - http://www.scopus.com/inward/record.url?scp=20044385568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044385568&partnerID=8YFLogxK

U2 - 10.1073/pnas.0409713102

DO - 10.1073/pnas.0409713102

M3 - Article

C2 - 15716361

AN - SCOPUS:20044385568

VL - 102

SP - 3413

EP - 3418

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 9

ER -